The project begins January 2013 and is funded by the German government, UNIDO announced in a statement November 21, 2012.
According to UNIDO, the new funding is expected to accelerate the implementation of the African Union’s Pharmaceutical Manufacturing Plan for Africa (PMPA), a joint endeavor with the African Union Commission.
A top official at the UN body indicated that unsatisfactory access to essential drugs is a key limitation that has had an impact on the health of the populations in a range of countries in Africa.
“Local manufacturers in developing countries could be a source of assured quality drugs, especially for the poor. Certified local production is also a way to combat counterfeit drugs, which endanger human lives,” said Kandeh K. Yumkella, UNIDO Director-General.
The project, will in the future be expanded to other African countries such as Mozambique, Nigeria, Tanzania, Uganda, and Zimbabwe, UNIDO indicated.
Since 2006, Germany, which is a key partner of UNIDO, has contributed over €80 million to develop the African pharmaceutical industry, the statement noted.
By Ekow Quandzie